Stephen Merlicek
Director/Board Member chez WCM GLOBAL GROWTH LIMITED
Fortune : 281 020 $ au 31/03/2024
Profil
Stephen Merlicek is currently the Chairman at Activus Investment Advisors, Infrastructure Partners Investment Fund, and The Walter & Eliza Hall Institute of Medical Research.
He is also a Director at AvSuper Pty Ltd.
and an Independent Non-Executive Director at WCM Global Growth Ltd.
since 2017.
Previously, he served as the Chief Investment Officer at Insignia Financial Ltd.
from 2009 to 2018.
He also held the position of Chief Investment Officer at Telstra Super Pty Ltd.
and United Funds Management Ltd.
Mr. Merlicek has a graduate degree from the University of Melbourne and an undergraduate degree from Monash University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
WCM GLOBAL GROWTH LTD.
0,16% | 28/03/2024 | 285 265 ( 0,16% ) | 281 020 $ | 31/03/2024 |
Postes actifs de Stephen Merlicek
| Sociétés | Poste | Début |
|---|---|---|
| WCM GLOBAL GROWTH LIMITED | Director/Board Member | 27/04/2017 |
| Activus Investment Advisors | Chairman | - |
| Infrastructure Partners Investment Fund | Chairman | - |
AvSuper Pty Ltd.
 AvSuper Pty Ltd. Investment ManagersFinance AvSuper Pty Ltd. is a trustee of the AvSuper Fund, which has both accumulation and income stream USIs. The private company is based in Canberra, Australia and has subsidiaries in Australia. The Australian company will be closed on Monday, March 13th, 2023 due to a public holiday in ACT, VIC, and TAS. The CEO of the company is Michelle Wade. | Director/Board Member | - |
The Walter & Eliza Hall Institute of Medical Research
 The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Anciens postes connus de Stephen Merlicek
| Sociétés | Poste | Fin |
|---|---|---|
| INSIGNIA FINANCIAL LTD. | Chief Investment Officer | 01/01/2018 |
Telstra Super Pty Ltd.
 Telstra Super Pty Ltd. Investment ManagersFinance Telstra Super Pty Ltd. (Telstra Super) is the pension fund management subsidiary of Telstra Corp. Ltd. (ASX: TLS, ADR: TLSYY) in Australia. Headquartered in Melbourne and founded in 1990, Telstra Super provides superannuation services to current and former Telstra Group employees, employees of a Telstra-approved employer (Telstra Stores) and their families. | Chief Investment Officer | - |
United Funds Management Ltd.
 United Funds Management Ltd. Investment ManagersFinance United Funds Management Ltd. (United) is the fund management subsidiary of Australian Wealth Management Ltd., which in turn is part of IOOF Holdings Ltd. (SY: IFL), a leading provider of wealth management products and services in Australia. Established in 1993, the firm is based in Melbourne and provides investors with access to a range of 'blended' portfolios of leading fund managers in each asset class including sector specific funds and a selection of diversified funds. They also offer institutional managed investments across all major asset classes. | Chief Investment Officer | - |
Formation de Stephen Merlicek
| University of Melbourne | Graduate Degree |
| Monash University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INSIGNIA FINANCIAL LTD. | Finance |
| Entreprise privées | 7 |
|---|---|
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |
Telstra Super Pty Ltd.
Telstra Super Pty Ltd. Investment ManagersFinance Telstra Super Pty Ltd. (Telstra Super) is the pension fund management subsidiary of Telstra Corp. Ltd. (ASX: TLS, ADR: TLSYY) in Australia. Headquartered in Melbourne and founded in 1990, Telstra Super provides superannuation services to current and former Telstra Group employees, employees of a Telstra-approved employer (Telstra Stores) and their families. | Finance |
United Funds Management Ltd.
United Funds Management Ltd. Investment ManagersFinance United Funds Management Ltd. (United) is the fund management subsidiary of Australian Wealth Management Ltd., which in turn is part of IOOF Holdings Ltd. (SY: IFL), a leading provider of wealth management products and services in Australia. Established in 1993, the firm is based in Melbourne and provides investors with access to a range of 'blended' portfolios of leading fund managers in each asset class including sector specific funds and a selection of diversified funds. They also offer institutional managed investments across all major asset classes. | Finance |
AvSuper Pty Ltd.
AvSuper Pty Ltd. Investment ManagersFinance AvSuper Pty Ltd. is a trustee of the AvSuper Fund, which has both accumulation and income stream USIs. The private company is based in Canberra, Australia and has subsidiaries in Australia. The Australian company will be closed on Monday, March 13th, 2023 due to a public holiday in ACT, VIC, and TAS. The CEO of the company is Michelle Wade. | Finance |
WCM Global Growth Ltd.
 WCM Global Growth Ltd. Investment Trusts/Mutual FundsMiscellaneous WCM Global Growth Ltd. engages in the business of investing in companies listed on global share markets. The firm is also involved in providing investors with access to an actively managed portfolio of quality global companies found primarily in the high growth consumer, technology, and healthcare sectors. The company was founded on February 9, 2017 and is headquartered in Sydney, Australia. | Miscellaneous |
| Activus Investment Advisors | |
| Infrastructure Partners Investment Fund |
